Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;93:810-816

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akimoto, H.
Right arrow Articles by Hiroe, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akimoto, H.
Right arrow Articles by Hiroe, M.

(Circulation. 1996;93:810-816.)
© 1996 American Heart Association, Inc.


Articles

Heparin and Heparan Sulfate Block Angiotensin IIInduced Hypertrophy in Cultured Neonatal Rat Cardiomyocytes

A Possible Role of Intrinsic Heparin-like Molecules in Regulation of Cardiomyocyte Hypertrophy

Hajime Akimoto, MD; Hiroshi Ito, MD; Masato Tanaka, MD; Susumu Adachi, MD; Mimi Hata, MD; Meihong Lin, MD; Hiroyuki Fujisaki, MD; Fumiaki Marumo, MD; Michiaki Hiroe, MD

From the Second Department of Internal Medicine, Tokyo (Japan) Medical and Dental University.

Correspondence to Hiroshi Ito, MD, Second Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113 Japan.

Background Heparan sulfate, one of the primary components of extracellular matrix, is a potent antigrowth factor in certain types of cells. To elucidate a possible role of endogenous heparin-like molecules in regulating cardiomyocyte hypertrophy, we investigated the effects of heparin and heparan sulfate on angiotensin (Ang) II–induced hypertrophy in cultured neonatal rat cardiomyocytes.

Methods and Results Competitive [3H]heparin binding assay showed that cardiomyocytes had specific binding sites for heparin. In situ [3H]heparin binding assay demonstrated that heparin, which rapidly bound to the cardiomyocyte surface, was subsequently accumulated around the nuclei, suggesting that heparin might work in the nucleus. Cotreatment with heparin (20 µg/mL) completely inhibited increased cell surface area by Ang II (10-6 mol/L). Increased [3H]leucine incorporation by Ang II was reduced by heparin dose-dependently. The inhibitory effect of heparin on Ang II–induced cardiomyocyte hypertrophy also was confirmed by Northern blot analysis: heparin dose-dependently inhibited skeletal {alpha}-actin and atrial natriuretic peptide gene expression, genetic markers for cardiomyocyte hypertrophy. Heparan sulfate showed similar inhibitory effects on cell surface area, [3H]leucine incorporation, and skeletal {alpha}-actin gene expression. Treatment with heparinase I or III, which specifically digests the disaccharide chains of endogenous heparin-like molecules, upregulated protein synthesis and skeletal {alpha}-actin and atrial natriuretic peptide gene expression in cardiomyocytes.

Conclusions Our findings in this study strongly suggest that heparin and heparan sulfate are potent inhibitors of cardiomyocyte hypertrophy and that endogenous heparin-like substances negatively regulate cardiomyocyte hypertrophy.


Key Words: angiotensin • heparin • hypertrophy




This article has been cited by other articles:


Home page
Circ. Res.Home page
B. Ramkhelawon, J. Vilar, D. Rivas, B. Mees, R. de Crom, A. Tedgui, and S. Lehoux
Shear Stress Regulates Angiotensin Type 1 Receptor Expression in Endothelial Cells
Circ. Res., October 23, 2009; 105(9): 869 - 875.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Maekawa, J.-i. Abe, T. Shishido, S. Itoh, B. Ding, V. K. Sharma, S.-S. Sheu, B. C. Blaxall, and B. C. Berk
Inhibiting p90 Ribosomal S6 Kinase Prevents Na+-H+ Exchanger-Mediated Cardiac Ischemia-Reperfusion Injury
Circulation, May 30, 2006; 113(21): 2516 - 2523.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. H. Thourani, S. S. Brar, T. P. Kennedy, L. R. Thornton, J. A. Watts, R. S. Ronson, Z.-Q. Zhao, A. L. Sturrock, J. R. Hoidal, and J. Vinten-Johansen
Nonanticoagulant heparin inhibits NF-kappa B activation and attenuates myocardial reperfusion injury
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2084 - H2093.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S.-L. Lee, W.-W. Wang, P. M. Joseph, C. A. Hales, and B. L. Fanburg
Inhibitory Effect of Heparin on Serotonin-induced Hyperplasia and Hypertrophy of Smooth Muscle Cells
Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 78 - 83.
[Abstract] [Full Text]